The Gut Nexus: Unraveling Microbiota-Mediated Links Between Type 2 Diabetes and Colorectal Cancer
Nutrients · 04.12.2025 · 17 (23) · 3803
DOI: 10.3390/nu17233803 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 04.12.2025. Verfasst von Anns Mahboob und 5 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine-Qatar, Doha P.O. Box 24144, Qatar. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Colorectal Neoplasms, Gastrointestinal Microbiome, Dysbiosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar National Research Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Colorectal cancer (CRC) and type 2 diabetes mellitus (T2DM) are two of the most rapidly rising chronic diseases globally. Despite appearing distinct, an emerging body of literature identifies shared etiopathogenic mechanisms mediated by gut microbiota. This review synthesizes 38 peer-reviewed studies to evaluate the compositional, metabolic, immune, and translational intersections of gut dysbiosis in the pathogenesis of T2DM-associated CRC.
Methods
This narrative literature review examined 38 primary research articles (human and animal studies) retrieved from PubMed, Scopus, and Embase. Studies were selected based on relevance to the microbiota-mediated mechanisms linking T2DM and CRC, with a focus on compositional analysis, metabolomic shifts, immune activation, and therapeutic interventions.
Results
The findings highlight a mechanistically rich overlap between T2DM and CRC through shared dysbiosis, characterized by depletion of SCFA-producing taxa (e.g., Faecalibacterium, Roseburia, Butyricicoccus), enrichment of pathobionts (e.g., Fusobacterium nucleatum, Peptostreptococcus), and the disruption of mucosal immunity and epithelial integrity. Metabolic shifts include reduced butyrate and increased toxic bile acids (e.g., deoxycholic acid), TMAO, and oxidative metabolites, while immune dysregulation features elevated LPS, IL-1β, CXCL3, and NF-κB signaling. Therapeutically, microbiota modulation via diet, metformin, and probiotics shows promise.
Conclusions
Gut microbiota lies at the nexus of T2DM and CRC, functioning as a modifiable mediator rather than a passive bystander. Future research should prioritize longitudinal, multi-omic, and intervention-driven studies to enable personalized prevention and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Weill Cornell Medicine-Qatar, Doha P.O. Box 24144, Qatar.
- Center of Experimental and Clinical Regenerative Medicine, Small Animal Clinic, University of Veterinary Medicine and Pharmacy, 041 81 Košice, Slovakia.
ORCID-Profile: Anns Mahboob, Chehbin Shin, Shahd Almughanni, Lubica Hornakova, Peter Kubatka, Dietrich Büsselberg
Förderung
- Qatar National Research Fund
Zitieren
APA
Mahboob, A., Shin, C., Almughanni, S., Hornakova, L., Kubatka, P., & Büsselberg, D. (2025). The Gut Nexus: Unraveling Microbiota-Mediated Links Between Type 2 Diabetes and Colorectal Cancer. Nutrients, 17(23), 3803. https://doi.org/10.3390/nu17233803
Vancouver
Mahboob A, Shin C, Almughanni S, Hornakova L, Kubatka P, Büsselberg D. The Gut Nexus: Unraveling Microbiota-Mediated Links Between Type 2 Diabetes and Colorectal Cancer. Nutrients. 2025;17(23):3803. doi:10.3390/nu17233803
BibTeX
@article{Mahboob2025,
author = {Mahboob, Anns and Shin, Chehbin and Almughanni, Shahd and Hornakova, Lubica and Kubatka, Peter and Büsselberg, Dietrich},
title = {The Gut Nexus: Unraveling Microbiota-Mediated Links Between Type 2 Diabetes and Colorectal Cancer},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {23},
pages = {3803},
doi = {10.3390/nu17233803}
}
EUVIMED